199 related articles for article (PubMed ID: 17383874)
1. 2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors.
Li JJ; Wang H; Tino JA; Robl JA; Herpin TF; Lawrence RM; Biller S; Jamil H; Ponticiello R; Chen L; Chu CH; Flynn N; Cheng D; Zhao R; Chen B; Schnur D; Obermeier MT; Sasseville V; Padmanabha R; Pike K; Harrity T
Bioorg Med Chem Lett; 2007 Jun; 17(11):3208-11. PubMed ID: 17383874
[TBL] [Abstract][Full Text] [Related]
2. ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo.
Gribble AD; Ife RJ; Shaw A; McNair D; Novelli CE; Bakewell S; Shah VP; Dolle RE; Groot PH; Pearce N; Yates J; Tew D; Boyd H; Ashman S; Eggleston DS; Haltiwanger RC; Okafo G
J Med Chem; 1998 Sep; 41(19):3582-95. PubMed ID: 9733484
[TBL] [Abstract][Full Text] [Related]
3. ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme.
Gribble AD; Dolle RE; Shaw A; McNair D; Novelli R; Novelli CE; Slingsby BP; Shah VP; Tew D; Saxty BA; Allen M; Groot PH; Pearce N; Yates J
J Med Chem; 1996 Aug; 39(18):3569-84. PubMed ID: 8784456
[TBL] [Abstract][Full Text] [Related]
4. Mono- and disalicylic acid derivatives: PTP1B inhibitors as potential anti-obesity drugs.
Shrestha S; Bhattarai BR; Lee KH; Cho H
Bioorg Med Chem; 2007 Oct; 15(20):6535-48. PubMed ID: 17692525
[TBL] [Abstract][Full Text] [Related]
5. Exploration of pyridine containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors.
Motiwala H; Kandre S; Birar V; Kadam KS; Rodge A; Jadhav RD; Mahesh Kumar Reddy M; Brahma MK; Deshmukh NJ; Dixit A; Doshi L; Gupte A; Gangopadhyay AK; Vishwakarma RA; Srinivasan S; Sharma M; Nemmani KV; Sharma R
Bioorg Med Chem Lett; 2011 Oct; 21(19):5812-7. PubMed ID: 21868220
[TBL] [Abstract][Full Text] [Related]
6. Cetilistat (ATL-962), a novel pancreatic lipase inhibitor, ameliorates body weight gain and improves lipid profiles in rats.
Yamada Y; Kato T; Ogino H; Ashina S; Kato K
Horm Metab Res; 2008 Aug; 40(8):539-43. PubMed ID: 18500680
[TBL] [Abstract][Full Text] [Related]
7. Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists.
Pasternak A; Goble SD; deJesus RK; Hreniuk DL; Chung CC; Tota MR; Mazur P; Feighner SD; Howard AD; Mills SG; Yang L
Bioorg Med Chem Lett; 2009 Nov; 19(21):6237-40. PubMed ID: 19767208
[TBL] [Abstract][Full Text] [Related]
8. The discovery of azepane sulfonamides as potent 11beta-HSD1 inhibitors.
Neelamkavil SF; Boyle CD; Chackalamannil S; Greenlee WJ; Zhang L; Terracina G
Bioorg Med Chem Lett; 2009 Aug; 19(16):4563-5. PubMed ID: 19625185
[TBL] [Abstract][Full Text] [Related]
9. 1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesity.
Vachal P; Fletcher JM; Fong TM; Huang CC; Lao J; Xiao JC; Shen CP; Strack AM; Shearman L; Stribling S; Chen RZ; Frassetto A; Tong X; Wang J; Ball RG; Tsou NN; Hickey GJ; Thompson DF; Faidley TD; Nicolich S; Achanfuo-Yeboah J; Hora DF; Hale JJ; Hagmann WK
J Med Chem; 2009 Apr; 52(8):2550-8. PubMed ID: 19320488
[TBL] [Abstract][Full Text] [Related]
10. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076.
Pearce NJ; Yates JW; Berkhout TA; Jackson B; Tew D; Boyd H; Camilleri P; Sweeney P; Gribble AD; Shaw A; Groot PH
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):113-9. PubMed ID: 9693110
[TBL] [Abstract][Full Text] [Related]
11. Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects.
Bhattarai BR; Kafle B; Hwang JS; Khadka D; Lee SM; Kang JS; Ham SW; Han IO; Park H; Cho H
Bioorg Med Chem Lett; 2009 Nov; 19(21):6161-5. PubMed ID: 19783142
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors.
Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S
Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, SAR and intramolecular hydrogen bonding pattern of 1,3,5-trisubstituted 4,5-dihydropyrazoles as potent cannabinoid CB(1) receptor antagonists.
Lange JH; van der Neut MA; den Hartog AP; Wals HC; Hoogendoorn J; van Stuivenberg HH; van Vliet BJ; Kruse CG
Bioorg Med Chem Lett; 2010 Mar; 20(5):1752-7. PubMed ID: 20137935
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel orally active ureido NPY Y5 receptor antagonists.
Li G; Stamford AW; Huang Y; Cheng KC; Cook J; Farley C; Gao J; Ghibaudi L; Greenlee WJ; Guzzi M; van Heek M; Hwa JJ; Kelly J; Mullins D; Parker EM; Wainhaus S; Zhang X
Bioorg Med Chem Lett; 2008 Feb; 18(3):1146-50. PubMed ID: 18160282
[TBL] [Abstract][Full Text] [Related]
15. First identification of xanthone sulfonamides as potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
Hu H; Liao H; Zhang J; Wu W; Yan J; Yan Y; Zhao Q; Zou Y; Chai X; Yu S; Wu Q
Bioorg Med Chem Lett; 2010 May; 20(10):3094-7. PubMed ID: 20403694
[TBL] [Abstract][Full Text] [Related]
16. Derivatives of 1,4-bis(3-hydroxycarbonyl-4-hydroxyl)styrylbenzene as PTP1B inhibitors with hypoglycemic activity.
Shrestha S; Bhattarai BR; Kafle B; Lee KH; Cho H
Bioorg Med Chem; 2008 Sep; 16(18):8643-52. PubMed ID: 18722777
[TBL] [Abstract][Full Text] [Related]
17. Potent biphenyl- and 3-phenyl pyridine-based inhibitors of acetyl-CoA carboxylase.
Haque TS; Liang N; Golla R; Seethala R; Ma Z; Ewing WR; Cooper CB; Pelleymounter MA; Poss MA; Cheng D
Bioorg Med Chem Lett; 2009 Oct; 19(20):5872-6. PubMed ID: 19740659
[TBL] [Abstract][Full Text] [Related]
18. Discovery of potent and orally active MTP inhibitors as potential anti-obesity agents.
Li J; Bertinato P; Cheng H; Cole BM; Bronk BS; Jaynes BH; Hickman A; Haven ML; Kolosko NL; Barry CJ; Manion TB
Bioorg Med Chem Lett; 2006 Jun; 16(11):3039-42. PubMed ID: 16529928
[TBL] [Abstract][Full Text] [Related]
19. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
Lee MS; Kim CT; Kim Y
Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166
[TBL] [Abstract][Full Text] [Related]
20. Anti-obesity compounds in green leaves of Eucommia ulmoides.
Hirata T; Kobayashi T; Wada A; Ueda T; Fujikawa T; Miyashita H; Ikeda T; Tsukamoto S; Nohara T
Bioorg Med Chem Lett; 2011 Mar; 21(6):1786-91. PubMed ID: 21324693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
